日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting STE20-type kinase MST3 improves metabolic dysfunction-associated steatohepatitis without affecting hepatocellular carcinoma development in mice

靶向STE20型激酶MST3可改善小鼠代谢功能障碍相关的脂肪性肝炎,且不影响肝细胞癌的发生发展。

Zhang, Jingjing; Gongye, Xiangdong; Kovooru, Lohitesh; Andersson, Emma; Asiedu, Bernice; Amrutkar, Manoj; Gul, Nadia; Myers, Caitlyn; Booten, Sheri; Lind, Dan Emil; Xia, Ying; Molinaro, Antonio; Härtlova, Anetta; Lindahl, Per; Murray, Sue; Mahlapuu, Margit

Inhibition of GCKIII kinases STK25 and MST3 mitigates organ lipotoxicity and enhances metabolic resilience under nutritional stress

抑制GCKIII激酶STK25和MST3可减轻器官脂毒性,并增强营养应激下的代谢韧性。

Andersson, Emma; Gongye, Xiangdong; Cansby, Emmelie; Zhang, Jingjing; Caputo, Mara; Asiedu, Bernice; Garellick, Viktor; Booten, Sheri; Murray, Sue; Font-Gironès, Ferran; Ruud, Johan; Lind, Dan Emil; Amrutkar, Manoj; Howell, Brian W; Wernstedt Asterholm, Ingrid; Mahlapuu, Margit

Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular Carcinoma

STE20型激酶STK25抑制剂在预防和治疗代谢性肝细胞癌中的治疗潜力

Ying Xia,Mara Caputo,Emma Andersson,Bernice Asiedu,Jingjing Zhang,Wei Hou,Manoj Amrutkar,Emmelie Cansby,Nadia Gul,Anne Gemmink,Caitlyn Myers,Mariam Aghajan,Sheri Booten,Andrew J Hoy,Anetta Härtlova,Per Lindahl,Anders Ståhlberg,Gert Schaart,Matthijs K C Hesselink,Andreas Peter,Sue Murray,Margit Mahlapuu

Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular Carcinoma

STE20型激酶STK25抑制剂在预防和治疗代谢性肝细胞癌中的治疗潜力

Ying Xia ,Mara Caputo ,Emma Andersson ,Bernice Asiedu ,Jingjing Zhang ,Wei Hou ,Manoj Amrutkar ,Emmelie Cansby ,Nadia Gul ,Anne Gemmink ,Caitlyn Myers ,Mariam Aghajan ,Sheri Booten ,Andrew J Hoy ,Anetta Härtlova ,Per Lindahl ,Anders Ståhlberg ,Gert Schaart ,Matthijs K C Hesselink ,Andreas Peter ,Sue Murray ,Margit Mahlapuu

Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice

反义寡核苷酸可改善足细胞特异性 APOL1 风险变异小鼠的肾功能障碍

Ya-Wen Yang, Bibek Poudel, Julia Frederick, Poonam Dhillon, Rojesh Shrestha, Ziyuan Ma, Junnan Wu, Koji Okamoto, Jeffrey B Kopp, Sheri L Booten, Danielle Gattis, Andrew T Watt, Matthew Palmer, Mariam Aghajan, Katalin Susztak

Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data

用于治疗转甲状腺素蛋白淀粉样变性的配体偶联反义寡核苷酸:临床前和 I 期数据

Viney, Nicholas J; Guo, Shuling; Tai, Li-Jung; Baker, Brenda F; Aghajan, Mariam; Jung, Shiangtung W; Yu, Rosie Z; Booten, Sheri; Murray, Heather; Machemer, Todd; Burel, Sebastien; Murray, Sue; Buchele, Gustavo; Tsimikas, Sotirios; Schneider, Eugene; Geary, Richard S; Benson, Merrill D; Monia, Brett P

Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity

通过限制铁摄入和调节促红细胞生成素活性的联合疗法来纠正β-地中海贫血

Casu, Carla; Pettinato, Mariateresa; Liu, Alison; Aghajan, Mariam; Lo Presti, Vania; Lidonnici, Maria Rosa; Munoz, Kevin A; O'Hara, Emir; Olivari, Violante; Di Modica, Simona Maria; Booten, Sheri; Guo, Shuling; Neil, Garry; Miari, Reem; Shapir, Nir; Zafir-Lavie, Inbal; Domev, Hagit; Ferrari, Giuliana; Sitara, Despina; Nai, Antonella; Rivella, Stefano

Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease

将 Stk25 反义寡核苷酸靶向递送至肝细胞可保护小鼠免受非酒精性脂肪肝疾病的侵害

Emmelie Cansby, Esther Nuñez-Durán, Elin Magnusson, Manoj Amrutkar, Sheri L Booten, Nagaraj M Kulkarni, L Thomas Svensson, Jan Borén, Hanns-Ulrich Marschall, Mariam Aghajan, Margit Mahlapuu

Antisense oligonucleotide treatment ameliorates IFN-γ-induced proteinuria in APOL1-transgenic mice

反义寡核苷酸治疗可改善 APOL1 转基因小鼠中 IFN-γ 诱导的蛋白尿

Mariam Aghajan, Sheri L Booten, Magnus Althage, Christopher E Hart, Anette Ericsson, Ingela Maxvall, Joseph Ochaba, Angela Menschik-Lundin, Judith Hartleib, Steven Kuntz, Danielle Gattis, Christine Ahlström, Andrew T Watt, Jeffery A Engelhardt, Brett P Monia, Maria Chiara Magnone, Shuling Guo

Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice

丝氨酸/苏氨酸蛋白激酶25反义寡核苷酸治疗可逆转小鼠的葡萄糖耐受不良、胰岛素抵抗和非酒精性脂肪肝疾病。

Nuñez-Durán, Esther; Aghajan, Mariam; Amrutkar, Manoj; Sütt, Silva; Cansby, Emmelie; Booten, Sheri L; Watt, Andrew; Ståhlman, Marcus; Stefan, Norbert; Häring, Hans-Ulrich; Staiger, Harald; Borén, Jan; Marschall, Hanns-Ulrich; Mahlapuu, Margit